戻る Agenda
SESSION 1:ICH REFORM AND DIA CONTRIBUTION
Session Chair(s)
Kazumichi Kobayashi, RPH
Executive Deputy President (Board Member)
Otsuka Medical Devices Co., Ltd., Japan
Junko Sato, PHD
Associate Executive Director
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Speaker(s)
Overview of ICH Reform and Its Vision
Lenita Lindström, LLM
European Commission, Belgium
ICH Assembly Chair and Senior Expert, European Commission
ICH Reform and Asian Regulatory Convergence
Toshiyoshi Tominaga, PHD
SunFlare Co., Ltd, Japan
Life Science Department, Advisor
DIA’s Contribution for ICH – Role of a Platform
Tatsuo Kurokawa, DIAFellow, PHD
The Japan Biosimilar Association, Japan
Director General